Tower Research Capital LLC (Trc) Volitionrx LTD Call Options Transaction History
Tower Research Capital LLC (Trc)
- $4.07 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VNRX
# of Institutions
27Shares Held
7.96MCall Options Held
39KPut Options Held
0-
Lagoda Investment Management, L.P. New York, NY5.07MShares$3.2 Million2.39% of portfolio
-
Vanguard Group Inc Valley Forge, PA636KShares$400,7850.0% of portfolio
-
Geode Capital Management, LLC Boston, MA617KShares$388,9400.0% of portfolio
-
Black Rock Inc. New York, NY574KShares$361,4680.0% of portfolio
-
Cowen Prime Advisors LLC179KShares$112,6040.09% of portfolio
About VOLITIONRX LTD
- Ticker VNRX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 57,297,000
- Market Cap $36.1M
- Description
- VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...